Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fussenegger

Showing results (121-130 of 330) with videos related to

Pageof 33
Sort By:
Current Opinion in Biotechnology|February 14, 2015
Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disordersBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Nature Reviews. Genetics|March 12, 2026
Next-generation programmable cell therapies for precision medicineAna Palma Teixeira, Dominique Aubel, Martin Fussenegger
Small (Weinheim an Der Bergstrasse, Germany)|July 31, 2023
Hydratable Core-Shell Polymer Networks for Atmospheric Water Harvesting Powered by SunlightDebasis Maity, Ana Palma Teixeira, Martin Fussenegger
Journal of Biotechnology|February 4, 2014
Heterogeneity of baseline neural marker expression by undifferentiated mesenchymal stem cells may be correlated to donor ageBoon Chin Heng, Pratik Saxena, Martin Fussenegger
Annual Review of Pharmacology and Toxicology|October 29, 2013
G protein-coupled receptors revisited: therapeutic applications inspired by synthetic biologyBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Metabolic Engineering|September 6, 2005
Semi-synthetic mammalian gene regulatory networksBeat P Kramer, Monika Fischer, Martin Fussenegger
Metabolic Engineering|September 12, 2006
6-hydroxy-nicotine-inducible multilevel transgene control in mammalian cellsLaetitia Malphettes, Ronald G Schoenmakers, Martin Fussenegger
Biotechnology and Bioengineering|April 28, 2007
A genetic time-delay circuitry in mammalian cellsWilfried Weber, Beat P Kramer, Martin Fussenegger
Biotechnology and Bioengineering|August 3, 2004
BioLogic gates enable logical transcription control in mammalian cellsBeat P Kramer, Cornelius Fischer, Martin Fussenegger
Current Opinion in Chemical Biology|July 3, 2021
Emerging mammalian gene switches for controlling implantable cell therapiesOliver Madderson, Ana Palma Teixeira, Martin Fussenegger
Pageof 33

Showing results (121-130 of 330) with videos related to

Sort By:
Pageof 33
Current Opinion in Biotechnology|February 14, 2015
Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disordersBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Nature Reviews. Genetics|March 12, 2026
Next-generation programmable cell therapies for precision medicineAna Palma Teixeira, Dominique Aubel, Martin Fussenegger
Small (Weinheim an Der Bergstrasse, Germany)|July 31, 2023
Hydratable Core-Shell Polymer Networks for Atmospheric Water Harvesting Powered by SunlightDebasis Maity, Ana Palma Teixeira, Martin Fussenegger
Journal of Biotechnology|February 4, 2014
Heterogeneity of baseline neural marker expression by undifferentiated mesenchymal stem cells may be correlated to donor ageBoon Chin Heng, Pratik Saxena, Martin Fussenegger
Annual Review of Pharmacology and Toxicology|October 29, 2013
G protein-coupled receptors revisited: therapeutic applications inspired by synthetic biologyBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Metabolic Engineering|September 6, 2005
Semi-synthetic mammalian gene regulatory networksBeat P Kramer, Monika Fischer, Martin Fussenegger
Metabolic Engineering|September 12, 2006
6-hydroxy-nicotine-inducible multilevel transgene control in mammalian cellsLaetitia Malphettes, Ronald G Schoenmakers, Martin Fussenegger
Biotechnology and Bioengineering|April 28, 2007
A genetic time-delay circuitry in mammalian cellsWilfried Weber, Beat P Kramer, Martin Fussenegger
Biotechnology and Bioengineering|August 3, 2004
BioLogic gates enable logical transcription control in mammalian cellsBeat P Kramer, Cornelius Fischer, Martin Fussenegger
Current Opinion in Chemical Biology|July 3, 2021
Emerging mammalian gene switches for controlling implantable cell therapiesOliver Madderson, Ana Palma Teixeira, Martin Fussenegger
Pageof 33